Ali Etemad-Rezaie , Serena Dienes , Chetan Gohal , Valerie Politis-Barber , Stephanie Searle , Diane Nam , Ujash Sheth
{"title":"复杂肱骨近端骨折的植骨增量选择:系统性综述","authors":"Ali Etemad-Rezaie , Serena Dienes , Chetan Gohal , Valerie Politis-Barber , Stephanie Searle , Diane Nam , Ujash Sheth","doi":"10.1016/j.jor.2024.07.017","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To systematically identify and evaluate different bone graft augmentation techniques in the operative treatment of complex proximal humerus fractures.</p></div><div><h3>Methods</h3><p>Four databases were searched from 1970 to February 2023 for Level I to IV English studies that investigated outcomes of different bone augments in the primary surgical fixation of proximal humerus fractures. The JBI critical appraisal checklist, methodological index for non-randomized studies and cochrane risk of bias tool were used to assess study quality. Descriptive statistics including weighted means are presented where applicable.</p></div><div><h3>Methods</h3><p>Thirty-three articles including 964 patients met the inclusion. Seven bone augments were identified, including fibular strut allograft (693 patients across 21 studies), femoral head allograft (84 patients across 4 studies), iliac crest allograft (54 patients across 3 studies), iliac crest autograft (94 patients across 5 studies), humeral endosteal allograft (6 patients in 1 single study), unspecified cancellous allograft (28 patients in 1 single study) and distal clavicle autograft (3 patients in 1 single study). Mean patient age was 67.1 years, with female patients comprising 65.2 %. Fracture union rates were similar between groups, with an average of 99.6 %. The average Constant Murley Score (CMS) was not reported in the humeral endosteal allograft or the distal clavicle autograft group but was 81.8 (fibular strut allograft), 79.1 (femoral head allograft), 76.8 (iliac crest allograft), 77.7 (iliac crest autograft), and 81.5 (unspecified cancellous allograft) in the remaining groups. Revision surgery was required in 16.7 % of patients receiving humeral endosteal allograft, 7 % of patients with femoral head allograft, 2 % of iliac crest autografts and 1.9 % in the fibular allograft group. Reported complications included avascular necrosis, hardware complications and loss of reduction.</p></div><div><h3>Conclusion</h3><p>Bone graft augmentation is an effective adjunct to open reduction internal fixation of complex proximal humerus fractures. Fibular strut allograft is the most common bone graft augment used. Majority of patients treated with bone graft augmentation achieved bony union (83%–100 %) and average CMS scores at final follow-up were similar between graft types (76–82). However, no conclusive data suggests superiority of one bone graft type over another. Future studies should aim to compare the outcomes amongst graft types.</p></div>","PeriodicalId":16633,"journal":{"name":"Journal of orthopaedics","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0972978X2400285X/pdfft?md5=77cd5cd9af380e0ca06fc4d0b0a8d249&pid=1-s2.0-S0972978X2400285X-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Bone grafting augmentation choices in complex proximal humerus fractures: A systematic review\",\"authors\":\"Ali Etemad-Rezaie , Serena Dienes , Chetan Gohal , Valerie Politis-Barber , Stephanie Searle , Diane Nam , Ujash Sheth\",\"doi\":\"10.1016/j.jor.2024.07.017\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>To systematically identify and evaluate different bone graft augmentation techniques in the operative treatment of complex proximal humerus fractures.</p></div><div><h3>Methods</h3><p>Four databases were searched from 1970 to February 2023 for Level I to IV English studies that investigated outcomes of different bone augments in the primary surgical fixation of proximal humerus fractures. The JBI critical appraisal checklist, methodological index for non-randomized studies and cochrane risk of bias tool were used to assess study quality. Descriptive statistics including weighted means are presented where applicable.</p></div><div><h3>Methods</h3><p>Thirty-three articles including 964 patients met the inclusion. Seven bone augments were identified, including fibular strut allograft (693 patients across 21 studies), femoral head allograft (84 patients across 4 studies), iliac crest allograft (54 patients across 3 studies), iliac crest autograft (94 patients across 5 studies), humeral endosteal allograft (6 patients in 1 single study), unspecified cancellous allograft (28 patients in 1 single study) and distal clavicle autograft (3 patients in 1 single study). Mean patient age was 67.1 years, with female patients comprising 65.2 %. Fracture union rates were similar between groups, with an average of 99.6 %. The average Constant Murley Score (CMS) was not reported in the humeral endosteal allograft or the distal clavicle autograft group but was 81.8 (fibular strut allograft), 79.1 (femoral head allograft), 76.8 (iliac crest allograft), 77.7 (iliac crest autograft), and 81.5 (unspecified cancellous allograft) in the remaining groups. Revision surgery was required in 16.7 % of patients receiving humeral endosteal allograft, 7 % of patients with femoral head allograft, 2 % of iliac crest autografts and 1.9 % in the fibular allograft group. Reported complications included avascular necrosis, hardware complications and loss of reduction.</p></div><div><h3>Conclusion</h3><p>Bone graft augmentation is an effective adjunct to open reduction internal fixation of complex proximal humerus fractures. Fibular strut allograft is the most common bone graft augment used. Majority of patients treated with bone graft augmentation achieved bony union (83%–100 %) and average CMS scores at final follow-up were similar between graft types (76–82). However, no conclusive data suggests superiority of one bone graft type over another. Future studies should aim to compare the outcomes amongst graft types.</p></div>\",\"PeriodicalId\":16633,\"journal\":{\"name\":\"Journal of orthopaedics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-07-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0972978X2400285X/pdfft?md5=77cd5cd9af380e0ca06fc4d0b0a8d249&pid=1-s2.0-S0972978X2400285X-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of orthopaedics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0972978X2400285X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ORTHOPEDICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of orthopaedics","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0972978X2400285X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0
摘要
方法在 1970 年至 2023 年 2 月期间的四个数据库中检索了调查肱骨近端骨折初次手术固定中不同骨增量效果的 I 至 IV 级英文研究。评估研究质量时使用了JBI关键评估清单、非随机研究方法学指数和cochrane偏倚风险工具。方法33篇文章包括964名患者符合纳入条件。确定了七种骨增强材料,包括腓骨支柱同种异体移植物(21项研究中的693例患者)、股骨头同种异体移植物(4项研究中的84例患者)、髂嵴同种异体移植物(3项研究中的54例患者)、髂嵴自体移植物(5项研究中的94例患者)、肱骨内骨骼同种异体移植物(1项单一研究中的6例患者)、未指定松质骨同种异体移植物(1项单一研究中的28例患者)和锁骨远端自体移植物(1项单一研究中的3例患者)。患者平均年龄为 67.1 岁,其中女性患者占 65.2%。各组骨折愈合率相似,平均为 99.6%。肱骨内骨骼同种异体移植组和锁骨远端自体移植组的平均恒定穆雷评分(CMS)未见报道,但其余各组的平均恒定穆雷评分分别为81.8(腓骨支柱同种异体移植)、79.1(股骨头同种异体移植)、76.8(髂嵴同种异体移植)、77.7(髂嵴自体移植)和81.5(未指定松质骨同种异体移植)。在接受肱骨内骨骼同种异体移植的患者中,16.7%需要进行翻修手术;在接受股骨头同种异体移植的患者中,7%需要进行翻修手术;在接受髂嵴自体移植的患者中,2%需要进行翻修手术;在接受腓骨同种异体移植的患者中,1.9%需要进行翻修手术。报告的并发症包括血管性坏死、硬件并发症和复位丧失。腓骨支柱异体移植物是最常用的骨移植增量材料。大多数接受骨移植增量治疗的患者都实现了骨性结合(83%-100%),不同移植类型患者在最终随访时的平均 CMS 评分相似(76-82)。然而,没有确凿的数据表明一种植骨类型优于另一种植骨类型。未来的研究应着眼于比较不同移植类型的结果。
Bone grafting augmentation choices in complex proximal humerus fractures: A systematic review
Objective
To systematically identify and evaluate different bone graft augmentation techniques in the operative treatment of complex proximal humerus fractures.
Methods
Four databases were searched from 1970 to February 2023 for Level I to IV English studies that investigated outcomes of different bone augments in the primary surgical fixation of proximal humerus fractures. The JBI critical appraisal checklist, methodological index for non-randomized studies and cochrane risk of bias tool were used to assess study quality. Descriptive statistics including weighted means are presented where applicable.
Methods
Thirty-three articles including 964 patients met the inclusion. Seven bone augments were identified, including fibular strut allograft (693 patients across 21 studies), femoral head allograft (84 patients across 4 studies), iliac crest allograft (54 patients across 3 studies), iliac crest autograft (94 patients across 5 studies), humeral endosteal allograft (6 patients in 1 single study), unspecified cancellous allograft (28 patients in 1 single study) and distal clavicle autograft (3 patients in 1 single study). Mean patient age was 67.1 years, with female patients comprising 65.2 %. Fracture union rates were similar between groups, with an average of 99.6 %. The average Constant Murley Score (CMS) was not reported in the humeral endosteal allograft or the distal clavicle autograft group but was 81.8 (fibular strut allograft), 79.1 (femoral head allograft), 76.8 (iliac crest allograft), 77.7 (iliac crest autograft), and 81.5 (unspecified cancellous allograft) in the remaining groups. Revision surgery was required in 16.7 % of patients receiving humeral endosteal allograft, 7 % of patients with femoral head allograft, 2 % of iliac crest autografts and 1.9 % in the fibular allograft group. Reported complications included avascular necrosis, hardware complications and loss of reduction.
Conclusion
Bone graft augmentation is an effective adjunct to open reduction internal fixation of complex proximal humerus fractures. Fibular strut allograft is the most common bone graft augment used. Majority of patients treated with bone graft augmentation achieved bony union (83%–100 %) and average CMS scores at final follow-up were similar between graft types (76–82). However, no conclusive data suggests superiority of one bone graft type over another. Future studies should aim to compare the outcomes amongst graft types.
期刊介绍:
Journal of Orthopaedics aims to be a leading journal in orthopaedics and contribute towards the improvement of quality of orthopedic health care. The journal publishes original research work and review articles related to different aspects of orthopaedics including Arthroplasty, Arthroscopy, Sports Medicine, Trauma, Spine and Spinal deformities, Pediatric orthopaedics, limb reconstruction procedures, hand surgery, and orthopaedic oncology. It also publishes articles on continuing education, health-related information, case reports and letters to the editor. It is requested to note that the journal has an international readership and all submissions should be aimed at specifying something about the setting in which the work was conducted. Authors must also provide any specific reasons for the research and also provide an elaborate description of the results.